IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials
February 28, 2020 | Silver Spring, MD

Overview

The FDA/AACR/IASLC Workshop to Address the Criticality ofTobacoo Use Assessment in Oncology Therapeutic Trials is a public workshop heldat the FDA in Silver Spring, MD. The aim of the workshop is to discuss theimportance of assessing and analyzing tobacco use in clinical trials and howthis assessment would help better treat patients and understand trial outcomes.

Venue

FDA White Oak Campus

A limited number of rooms are available for a special rate at the Sheraton Silver Spring for this event. If you are interested in booking one of these rooms, please email [email protected]

Register for the workshop.

Workshop Cochairs:

Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Associate Director for Translational Research, Yale Cancer Center

Michael E. Menefee, MD, Medical Oncologist, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Matthew Steliga, MD, Thoracic Surgeon, Winthrop P. Rockefeller Cancer Institute

Contact

Jeanette Stensgaard
Conference Planning Manager

Venue

FDA White Oak Campus